BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 20182054)

  • 1. Caffeine as a protective factor in dementia and Alzheimer's disease.
    Eskelinen MH; Kivipelto M
    J Alzheimers Dis; 2010; 20 Suppl 1():S167-74. PubMed ID: 20182054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study.
    Eskelinen MH; Ngandu T; Tuomilehto J; Soininen H; Kivipelto M
    J Alzheimers Dis; 2009; 16(1):85-91. PubMed ID: 19158424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caffeine and coffee as therapeutics against Alzheimer's disease.
    Arendash GW; Cao C
    J Alzheimers Dis; 2010; 20 Suppl 1():S117-26. PubMed ID: 20182037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diet and Alzheimer's disease risk factors or prevention: the current evidence.
    Solfrizzi V; Panza F; Frisardi V; Seripa D; Logroscino G; Imbimbo BP; Pilotto A
    Expert Rev Neurother; 2011 May; 11(5):677-708. PubMed ID: 21539488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caffeine, diabetes, cognition, and dementia.
    Biessels GJ
    J Alzheimers Dis; 2010; 20 Suppl 1():S143-50. PubMed ID: 20182038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: a systematic review.
    Panza F; Solfrizzi V; Barulli MR; Bonfiglio C; Guerra V; Osella A; Seripa D; Sabbà C; Pilotto A; Logroscino G
    J Nutr Health Aging; 2015 Mar; 19(3):313-28. PubMed ID: 25732217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caffeine intake is associated with a lower risk of cognitive decline: a cohort study from Portugal.
    Santos C; Lunet N; Azevedo A; de Mendonça A; Ritchie K; Barros H
    J Alzheimers Dis; 2010; 20 Suppl 1():S175-85. PubMed ID: 20182036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neuroprotective effects of caffeine: a prospective population study (the Three City Study).
    Ritchie K; Carrière I; de Mendonca A; Portet F; Dartigues JF; Rouaud O; Barberger-Gateau P; Ancelin ML
    Neurology; 2007 Aug; 69(6):536-45. PubMed ID: 17679672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coffee, tea, and caffeine consumption and risk of rheumatoid arthritis: results from the Iowa Women's Health Study.
    Mikuls TR; Cerhan JR; Criswell LA; Merlino L; Mudano AS; Burma M; Folsom AR; Saag KG
    Arthritis Rheum; 2002 Jan; 46(1):83-91. PubMed ID: 11817612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IANA task force on nutrition and cognitive decline with aging.
    Gillette Guyonnet S; Abellan Van Kan G; Andrieu S; Barberger Gateau P; Berr C; Bonnefoy M; Dartigues JF; de Groot L; Ferry M; Galan P; Hercberg S; Jeandel C; Morris MC; Nourhashemi F; Payette H; Poulain JP; Portet F; Roussel AM; Ritz P; Rolland Y; Vellas B
    J Nutr Health Aging; 2007; 11(2):132-52. PubMed ID: 17435956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.
    Arendash GW; Schleif W; Rezai-Zadeh K; Jackson EK; Zacharia LC; Cracchiolo JR; Shippy D; Tan J
    Neuroscience; 2006 Nov; 142(4):941-52. PubMed ID: 16938404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dementia: risk and protective factors with special consideration of gender and hormone replacement therapy].
    Stoppe G
    Z Arztl Fortbild Qualitatssich; 2000 Apr; 94(3):217-22. PubMed ID: 10802897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caffeine, cognition, and socioeconomic status.
    Kyle J; Fox HC; Whalley LJ
    J Alzheimers Dis; 2010; 20 Suppl 1():S151-9. PubMed ID: 20182052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Teratogen update: evaluation of the reproductive and developmental risks of caffeine.
    Christian MS; Brent RL
    Teratology; 2001 Jul; 64(1):51-78. PubMed ID: 11410911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of Alzheimer's disease and dementia. Major findings from the Kungsholmen Project.
    Fratiglioni L; Winblad B; von Strauss E
    Physiol Behav; 2007 Sep; 92(1-2):98-104. PubMed ID: 17588621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular risk factors and dementia.
    Fillit H; Nash DT; Rundek T; Zuckerman A
    Am J Geriatr Pharmacother; 2008 Jun; 6(2):100-18. PubMed ID: 18675769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dementia and Alzheimer's disease in community-dwelling elders taking vitamin C and/or vitamin E.
    Fillenbaum GG; Kuchibhatla MN; Hanlon JT; Artz MB; Pieper CF; Schmader KE; Dysken MW; Gray SL
    Ann Pharmacother; 2005 Dec; 39(12):2009-14. PubMed ID: 16227448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort.
    Newman AB; Fitzpatrick AL; Lopez O; Jackson S; Lyketsos C; Jagust W; Ives D; Dekosky ST; Kuller LH
    J Am Geriatr Soc; 2005 Jul; 53(7):1101-7. PubMed ID: 16108925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caffeine, cognitive failures and health in a non-working community sample.
    Smith AP
    Hum Psychopharmacol; 2009 Jan; 24(1):29-34. PubMed ID: 19016251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors.
    Fournier A; Oprisiu-Fournier R; Serot JM; Godefroy O; Achard JM; Faure S; Mazouz H; Temmar M; Albu A; Bordet R; Hanon O; Gueyffier F; Wang J; Black S; Sato N
    Expert Rev Neurother; 2009 Sep; 9(9):1413-31. PubMed ID: 19769454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.